HealthcarePre-market
Dr Lal PathLabs reports 10.7% revenue growth, approves bonus issue
pre-market1 source ↓written by the desknot a recommendation
- from ₹660 crore
- 10.7% increase
- after tax rose
- 16.4%
- ₹152 crore
- and declared
- 1:1 bonus share issue
- interim dividend
- ₹7 per share
Dr Lal PathLabs announced revenue of ₹731 crore for Q2FY26, a 10.7% increase from ₹660 crore last year. Profit after tax rose 16.4% to ₹152 crore. The company also approved a 1:1 bonus share issue and declared an interim dividend of ₹7 per share. This growth reflects increased testing volumes and network expansion.
Not investment advice. For informational purposes only.